Elsevier

Nutrition

Volume 17, Issue 9, September 2001, Pages 769-772
Nutrition

PENSA meeting
Cancer: impact of nutrition intervention outcome—nutrition issues for patients

https://doi.org/10.1016/S0899-9007(01)00632-3Get rights and content

Abstract

OBJECTIVE: We examined nutritional issues, assessment, and intervention strategies for patients with cancer.

METHODS: Reviews of practice guidelines and published reports were used to identify nutritional issues and strategies that can benefit patients with cancer.

RESULTS: Assessment tools such as the Patient-Generated Subjective Global Assessment are useful in terms of identifying patients with nutrition issues and guiding intervention. However, quality of life and other measures should also be considered. There is a need for early and ongoing nutrition interventions.

CONCLUSIONS: Encourage patients to try a new food or supplement on days when they are not receiving chemotherapy or radiation therapy because it may result in better tolerance. Screen patients to determine their nutritional status. Closely monitor changes in weight, food intake, and symptoms such as nausea and vomiting. Refer to a registered dietitian for a complete nutrition assessment and individualized counseling.

Introduction

In Western countries, cancer is the second leading cause of death. More than 1.2 million new cases of cancer were expected to be diagnosed in the United States in 1998 (a 2% decrease from 1997 incidence statistics), and in Australia there are about 345 000 new cases a year, 270 000 of which are skin cancers.1, 2 More than 500 000 Americans were expected to die from cancer in 1998—that is, approximately 1500 people a day.1 In Australia 28% of male deaths and 25% of female deaths are from cancer.2 Survival rates have improved, with the 5-y relative survival rate increasing from 52% (1980–1982 data) to an estimated 60% (based on 1986–1993 data).1

Section snippets

Prevalence of malnutrition and weight loss in patients with cancer

Nutritional decline is often accepted as part of the cancer course and its treatment. The prevalence of weight loss and malnutrition in patients has been reported to range from 9% in patients with breast cancer to 80% in patients with esophageal cancer.3, 4, 5 In addition, as many as 20% of patients with cancer die from the effects of malnutrition rather than the malignancy.6

Patients with cancer of the lung, esophagus, stomach, colon, rectum, liver, and pancreas are at greatest risk of weight

Etiology of malnutrition in patients with cancer

The etiology of malnutrition in patients with cancer is multifactorial.8 Malnutrition can result from the systemic effects of the tumor, the local effects of the tumor, or the side effects of anticancer treatment.11, 12 Systemic effects, such as anorexia and altered metabolism seen with cachexia, are multiple and differ in type and severity depending on the form of cancer. Local effects usually are associated with malabsorption, obstruction, diarrhea, and vomiting.13 Fatigue, depression,

Anorexia and cachexia

Anorexia, or the involuntary decline of food intake, occurs in at least half of newly diagnosed cancer patients. Mechanical anorexia, such as the inability of patients with esophageal cancer to consume adequate energy, is a major contributor to the development of malnutrition but often can be overcome by enteral feeding. Cancer cachexia is a complex metabolic syndrome in which patients experience anorexia, early satiety, weakness, anemia, sarcopenia, and severe weight loss.15, 16, 17 The

Surgery

The stress response observed with surgery is associated with hypermetabolism, tissue breakdown, and protein loss. This response leads to weight loss, fatigue, and a deterioration in functional status.25 Post-operative weight loss results from an increased energy expenditure due to the stress response and a decreased dietary intake.25

Patients who have undergone surgery of the head-and-neck area such as the oropharynx or esophagus might experience malnutrition due to a decreased ability to ingest

Chemotherapy

Chemotherapeutic drugs are toxic to the malignant tissue and normal host cells that have a high turnover rate, such as cells in the bone marrow; hair follicles; oral, esophageal, and gastrointestinal mucosa; and reproductive system.13 Damage to the mucosa of the gastrointestinal tract can adversely affect the digestion and absorption of nutrients. Antineoplastic agents such as cisplatin, doxorubicin, and fluorouracil can indirectly affect food intake, absorption, or use by inducing severe

Radiotherapy

The severity and extent to which patients undergoing radiation treatment experience side effects depend on the tumor and treatment site, duration of treatment, and radiation dose. Radiotherapy is toxic to tumor cells and normal host cells within the area of treatment. As with chemotherapy, rapidly dividing tissue cells, such as blood cells, hair follicles, and cells lining the gastrointestinal tract, are the most susceptible to radiation damage.13 Therefore, any treatment directed at the

Impact of malnutrition on outcomes in patients with cancer

Cancer cachexia regardless of its etiology has been associated with poor outcomes in patients with cancer. Malnutrition not only affects morbidity and mortality but also can lead to lower quality of life and a change in self-image.37, 38 The social aspects of eating are affected by reduced appetite, nausea, or vomiting. Nutrition affects functional status and well-being as malnourished patients experience weakness and fatigue, which can affect the ability to work or carry out activities of

Nutritional support in patients with cancer

The goal of nutritional support is to prevent or reverse the weight loss that often accompanies malignancy. As previously demonstrated, weight loss is associated with poor patient outcomes such as response to therapy, quality of life, and survival. Thus, preventing or reversing weight loss through nutritional support should improve patient outcomes, e.g., performance status, functional status, appetite, and quality of life. Total parenteral nutrition, enteral nutrition, nutritional supplements,

Summary

Malnutrition is prevalent in cancer patients, especially those with solid tumors. Poor nutritional status can result in decreased quality of life, functional status, and response to therapy. Nutrition decline does not have to be an accepted part of cancer therapy. Screening cancer patients can determine who is at risk for malnutrition. Nutrition intervention, in the form of oral supplements and tube feeding, can affect patient outcomes. Nutrition is more than just food—it is a component of care

References (47)

  • M.D. Barber et al.

    Current controversies in cancershould cancer patients with incurable disease receive parenteral or enteral nutritional support?

    Eur J Cancer

    (1998)
  • M. Ferguson et al.

    Development of a valid and reliable malnutrition screening tool for adult acute hospital patients

    Nutrition

    (1999)
  • S.H. Landis et al.

    Cancer statistics 1998

    Cancer J Clin

    (1998)
  • Australian Institute of Health and Welfare and Australasian Association of Cancer Registries. Cancer in Australia,...
  • M.A.E. van Bokhorst-de van der Schueren et al.

    Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications

    Head Neck

    (1997)
  • F.D. Ottery

    Cancer cachexiaprevention, early diagnosis and management

    Cancer Pract

    (1994)
  • D.E. Rivadeneira et al.

    Nutritional support of the cancer patient

    Cancer J Clin

    (1998)
  • M.E. Shils

    Principles of nutritional therapy

    Cancer

    (1979)
  • A.S. Bloch

    Nutrition management of the cancer patient

    (1990)
  • M. Grosvenor et al.

    Symptoms potentially influencing weight loss in cancer population

    Cancer

    (1989)
  • K.C.H. Fearon et al.

    Cancer cachexia

    Ann Surg

    (1988)
  • A.M. Herrington et al.

    Pharmacologic options for the treatment of cachexia

    ASPEN

    (1997)
  • Giacosa A, Frascio F, Sukkar SG, Roncella S. Cytokines and nutritional response in cancer cachexia. Paper presented at...
  • Cited by (197)

    • Taste disorders in disease

      2022, Flavor: From Food to Behaviors, Wellbeing and Health, Second Edition
    View all citing articles on Scopus

    Financial support was provided by Abbott Laboratories, Columbus, Ohio, USA.

    View full text